Skip to content
2000
Volume 21, Issue 11
  • ISSN: 1567-2050
  • E-ISSN: 1875-5828

Abstract

Background

Alzheimer's disease is a chronic, neurodegenerative condition that leads to a significant cognitive decline. One of the symptoms that greatly reduces the quality of daily functioning is the deterioration of spatial orientation abilities. A non-pharmacological treatment option for Alzheimer's disease, which is also employed to improve the cognitive functioning of individuals with mild cognitive impairment, is virtual reality training.

Objective

To the best of the authors' knowledge, there is no existing systematic review on the use of virtual reality training to enhance spatial orientation in individuals with Alzheimer’s disease or mild cognitive impairment. The review was therefore conducted to fill this gap. The findings of this review may support the efficacy of virtual reality in enhancing spatial orientation.

Methods

Five databases were searched. The primary inclusion criteria were study participants aged over 60 years with a diagnosis of Alzheimer's disease or mild cognitive impairment and the use of virtual reality for improving spatial orientation. Six studies meeting these criteria were ultimately included in the review.

Results

All included studies demonstrated an improvement in the spatial orientation of individuals with Alzheimer's disease or mild cognitive impairment following virtual reality training. This indicates the effectiveness of virtual reality technology in cognitive rehabilitation.

Conclusion

As virtual reality cognitive training has proven effective, its use should be more widely adopted. Further research on the application of virtual reality for enhancing spatial orientation in individuals with dementia is recommended.

Loading

Article metrics loading...

/content/journals/car/10.2174/0115672050374807250224044204
2025-02-26
2025-06-18
Loading full text...

Full text loading...

References

  1. McKhannG.M. KnopmanD.S. ChertkowH. HymanB.T. JackC.R.Jr KawasC.H. KlunkW.E. KoroshetzW.J. ManlyJ.J. MayeuxR. MohsR.C. MorrisJ.C. RossorM.N. ScheltensP. CarrilloM.C. ThiesB. WeintraubS. PhelpsC.H. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease.Alzheimers Dement.20117326326910.1016/j.jalz.2011.03.00521514250
    [Google Scholar]
  2. LopezS.J.A. GonzálezH.M. LégerG.C. Alzheimer’s disease.Handb. Clin. Neurol.201916723125510.1016/B978‑0‑12‑804766‑8.00013‑331753135
    [Google Scholar]
  3. PashmdarfardM. AzadA. Assessment tools to evaluate activities of daily living (adl) and instrumental activities of daily living (IADL) in older adults: A systematic review.Med. J. Islam Rep. Iran.2020343310.34171/mjiri.34.33
    [Google Scholar]
  4. YuJ. WuJ. LiuB. ZhengK. RenZ. Efficacy of virtual reality technology interventions for cognitive and mental outcomes in older people with cognitive disorders: An umbrella review comprising meta-analyses of randomized controlled trials.Ageing Res. Rev.20249410217910.1016/j.arr.2023.10217938163517
    [Google Scholar]
  5. JormA.F. KortenA.E. HendersonA.S. The prevalence of dementia: A quantitative integration of the literature.Acta Psychiatr. Scand.198776546547910.1111/j.1600‑0447.1987.tb02906.x3324647
    [Google Scholar]
  6. BesseyL.J. WalaszekA. Management of behavioral and psychological symptoms of dementia.Curr. Psychiatry Rep.20192186610.1007/s11920‑019‑1049‑531264056
    [Google Scholar]
  7. DesaiA.K. SchwartzL. GrossbergG.T. Behavioral disturbance in dementia.Curr. Psychiatry Rep.201214429830910.1007/s11920‑012‑0288‑522644311
    [Google Scholar]
  8. TibleO.P. RieseF. SavaskanE. GuntenV.A. Best practice in the management of behavioural and psychological symptoms of dementia.Ther. Adv. Neurol. Disord.201710829730910.1177/175628561771297928781611
    [Google Scholar]
  9. CiprianiG. DantiS. PicchiL. NutiA. FiorinoM.D. Daily functioning and dementia.Dement. Neuropsychol.20201429310210.1590/1980‑57642020dn14‑02000132595877
    [Google Scholar]
  10. JonesD. A family living with Alzheimer’s disease: The communicative challenges.Dementia201514555557310.1177/147130121350221324339113
    [Google Scholar]
  11. O’NeilH.A. FletcherP.C. Sometimes life throws you a curve ball.Clin. Nurse Spec.202135631832610.1097/NUR.000000000000063534606212
    [Google Scholar]
  12. SchaberP. BlairK. JostE. SchafferM. ThurnerE. Understanding family interaction patterns in families with Alzheimer’s disease.OTJR2016361253310.1177/153944921561056627504690
    [Google Scholar]
  13. BottoR. CallaiN. CermelliA. CausaranoL. RaineroI. Anxiety and depression in Alzheimer’s disease: A systematic review of pathogenetic mechanisms and relation to cognitive decline.Neurol. Sci.20224374107412410.1007/s10072‑022‑06068‑x35461471
    [Google Scholar]
  14. ChiS. YuJ.T. TanM.S. TanL. Depression in Alzheimer’s disease: Epidemiology, mechanisms, and management.J. Alzheimers Dis.201442373975510.3233/JAD‑14032424946876
    [Google Scholar]
  15. FerrettiL. McCurryS.M. LogsdonR. GibbonsL. TeriL. Anxiety and Alzheimer’s disease.J. Geriatr. Psychiatry Neurol.2001141525810.1177/08919887010140011111281317
    [Google Scholar]
  16. LeungD.K.Y. ChanW.C. SpectorA. WongG.H.Y. Prevalence of depression, anxiety, and apathy symptoms across dementia stages: A systematic review and meta-analysis.Int. J. Geriatr. Psychiatry20213691330134410.1002/gps.555633905138
    [Google Scholar]
  17. LyketsosC.G. CarrilloM.C. RyanJ.M. KhachaturianA.S. TrzepaczP. AmatniekJ. CedarbaumJ. BrashearR. MillerD.S. Neuropsychiatric symptoms in Alzheimer’s disease.Alzheimers Dement.20117553253910.1016/j.jalz.2011.05.241021889116
    [Google Scholar]
  18. MendezM.F. The relationship between anxiety and Alzheimer’s disease.J. Alzheimers Dis. Rep.20215117117710.3233/ADR‑21029433981954
    [Google Scholar]
  19. PerriR. TurchettaC.S. CarusoG. FaddaL. CaltagironeC. CarlesimoG.A. Neuropsychological correlates of cognitive, emotional-affective and auto-activation apathy in Alzheimer's disease.Neuropsychologia2018118Pt B122110.1016/j.neuropsychologia.2018.01.039
    [Google Scholar]
  20. RodríguezC.B. CastiñeiraR.B. NunesC.L. Alzheimer's disease and quality of life of the informal caregiver.Rev. Esp. Geriatr. Gerontol.2019542818710.1016/j.regg.2018.10.00830792138
    [Google Scholar]
  21. GrabherB.J. Effects of Alzheimer disease on patients and their family.J. Nucl. Med. Technol.201846433534010.2967/jnmt.118.21805730139888
    [Google Scholar]
  22. HellisE. Mukaetova-LadinskaE.B. Informal caregiving and Alzheimer’s disease: The psychological effect.Medicina20225914810.3390/medicina5901004836676672
    [Google Scholar]
  23. RosaR.D.L. Simões-NetoJ.P. SantosR.L. TorresB. BaptistaM.A.T. KimuraN.R.S. DouradoM.C.N. Caregivers’ resilience in mild and moderate Alzheimer’s disease.Aging Ment. Health202024225025810.1080/13607863.2018.153352030499333
    [Google Scholar]
  24. BurksH.B. BordesD.J.K.A. ChadhaR. HolmesH.M. RianonN.J. Quality of life assessment in older adults with dementia: A systematic review.Dement. Geriatr. Cogn. Disord.202150210311010.1159/00051531734167127
    [Google Scholar]
  25. ChenY.X. LiangN. LiX.L. YangS.H. WangY.P. ShiN.N. Diagnosis and treatment for mild cognitive impairment: A systematic review of clinical practice guidelines and consensus statements.Front. Neurol.20211271984910.3389/fneur.2021.71984934712197
    [Google Scholar]
  26. HughesT.F. ChangC.C.H. BiltJ.V. SnitzB.E. GanguliM. Mild cognitive deficits and everyday functioning among older adults in the community: The Monongahela-Youghiogheny Healthy Aging Team study.Am. J. Geriatr. Psychiatry2012201083684410.1097/JGP.0b013e318242396122337146
    [Google Scholar]
  27. PetersenR.C. RobertsR.O. KnopmanD.S. GedaY.E. ChaR.H. PankratzV.S. BoeveB.F. TangalosE.G. IvnikR.J. RoccaW.A. Prevalence of mild cognitive impairment is higher in men.Neurology2010751088989710.1212/WNL.0b013e3181f11d8520820000
    [Google Scholar]
  28. BocciaM. VitaD.A. DianaS. MargiottaR. ImbrianoL. RendaceL. CampanelliA. D’AntonioF. TrebbastoniA. LenaD.C. PiccardiL. GuarigliaC. Is losing one’s way a sign of cognitive decay? topographical memory deficit as an early marker of pathological aging.J. Alzheimers Dis.201968267969310.3233/JAD‑18089030883347
    [Google Scholar]
  29. KavcicV. DuffyC.J. Attentional dynamics and visual perception: Mechanisms of spatial disorientation in Alzheimer’s disease.Brain200312651173118110.1093/brain/awg10512690056
    [Google Scholar]
  30. MonacelliA.M. CushmanL.A. KavcicV. DuffyC.J. Spatial disorientation in Alzheimer’s disease.Neurology200361111491149710.1212/WNL.61.11.149114663030
    [Google Scholar]
  31. ChiuY.C. AlgaseD. WhallA. LiangJ. LiuH.C. LinK.N. WangP.N. Getting lost: Directed attention and executive functions in early Alzheimer’s disease patients.Dement. Geriatr. Cogn. Disord.200417317418010.1159/00007635314739541
    [Google Scholar]
  32. deIpolyiA.R. RankinK.P. MuckeL. MillerB.L. Gorno-TempiniM.L. Spatial cognition and the human navigation network in AD and MCI.Neurology2007691098699710.1212/01.wnl.0000271376.19515.c617785667
    [Google Scholar]
  33. PuthusseryppadyV. MorrisseyS. SpiersH. PatelM. HornbergerM. Predicting real world spatial disorientation in Alzheimer’s disease patients using virtual reality navigation tests.Sci. Rep.20221211339710.1038/s41598‑022‑17634‑w35927285
    [Google Scholar]
  34. AllisonS.L. FaganA.M. MorrisJ.C. HeadD. Spatial navigation in preclinical Alzheimer's disease.J. Alzheimers Dis.2016521779010.3233/JAD‑150855
    [Google Scholar]
  35. HendersonV.W. MackW. WilliamsB.W. Spatial disorientation in Alzheimer’s disease.Arch. Neurol.198946439139410.1001/archneur.1989.005204000450182705898
    [Google Scholar]
  36. VlčekK. LaczóJ. Neural correlates of spatial navigation changes in mild cognitive impairment and Alzheimer’s disease.Front. Behav. Neurosci.201488910.3389/fnbeh.2014.0008924672452
    [Google Scholar]
  37. United nations. world population ageing 2020. highlights.2020Available from: https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/undesa_pd-2020_world_population_ageing_highlights.pdf
  38. Global Health and Aging.2021Available from: https://www.nia.nih.gov/sites/default/files/2017-06/global_health_aging.pdf
  39. Ageing and health.2021Available from: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health
  40. World health organization. dementia.2024Available from: https://www.who.int/news-room/fact-sheets/detail/dementia
  41. 2024 Alzheimer’s disease facts and figures.Alzheimers Dement.20242053708382110.1002/alz.1380938689398
    [Google Scholar]
  42. HongY.C. Aging society and environmental health challenges.Environ. Health Perspect.20131213A68A6910.1289/ehp.120633423454410
    [Google Scholar]
  43. RoweJ.W. Challenges for middle-income elders in an aging society.Health Aff.2019385101377hlthaff20190009510.1377/hlthaff.2019.00095
    [Google Scholar]
  44. WangH.X. MacDonaldS.W.S. DekhtyarS. FratiglioniL. Association of lifelong exposure to cognitive reserve-enhancing factors with dementia risk: A community-based cohort study.PLoS Med.2017143e100225110.1371/journal.pmed.100225128291786
    [Google Scholar]
  45. NicholsE. SteinmetzJ.D. VollsetS.E. FukutakiK. ChalekJ. Abd-AllahF. AbdoliA. AbualhasanA. Abu-GharbiehE. AkramT.T. HamadA.H. AlahdabF. AlaneziF.M. AlipourV. AlmustanyirS. AmuH. AnsariI. ArablooJ. AshrafT. Astell-BurtT. AyanoG. Ayuso-MateosJ.L. BaigA.A. BarnettA. BarrowA. BauneB.T. BéjotY. BezabheW.M.M. BezabihY.M. BhagavathulaA.S. BhaskarS. BhattacharyyaK. BijaniA. BiswasA. BollaS.R. BoloorA. BrayneC. BrennerH. BurkartK. BurnsR.A. CámeraL.A. CaoC. CarvalhoF. Castro-de-AraujoL.F.S. Catalá-LópezF. CerinE. ChavanP.P. CherbuinN. ChuD-T. CostaV.M. CoutoR.A.S. DadrasO. DaiX. DandonaL. DandonaR. la Cruz-GóngoraD.V. DhamnetiyaD. Dias da SilvaD. DiazD. DouiriA. EdvardssonD. EkholuenetaleM. SayedE.I. El-JaafaryS.I. EskandariK. EskandariehS. EsmaeilnejadS. FaresJ. FaroA. FarooqueU. FeiginV.L. FengX. FereshtehnejadS-M. FernandesE. FerraraP. FilipI. FillitH. FischerF. GaidhaneS. GalluzzoL. GhashghaeeA. GhithN. GialluisiA. GilaniS.A. GlavanI-R. GnedovskayaE.V. GolechhaM. GuptaR. GuptaV.B. GuptaV.K. HaiderM.R. HallB.J. HamidiS. HanifA. HankeyG.J. HaqueS. HartonoR.K. HasaballahA.I. HasanM.T. HassanA. HayS.I. HayatK. HegazyM.I. HeidariG. Heidari-SoureshjaniR. HerteliuC. HousehM. HussainR. HwangB-F. IacovielloL. IavicoliI. IlesanmiO.S. IlicI.M. IlicM.D. IrvaniS.S.N. IsoH. IwagamiM. JabbarinejadR. JacobL. JainV. JayapalS.K. JayawardenaR. JhaR.P. JonasJ.B. JosephN. KalaniR. KandelA. KandelH. KarchA. KasaA.S. KassieG.M. KeshavarzP. KhanM.A.B. KhatibM.N. KhojaT.A.M. KhubchandaniJ. KimM.S. KimY.J. KisaA. KisaS. KivimäkiM. KoroshetzW.J. KoyanagiA. KumarG.A. KumarM. LakH.M. LeonardiM. LiB. LimS.S. LiuX. LiuY. LogroscinoG. LorkowskiS. LucchettiG. SauteL.R. MagnaniF.G. MalikA.A. MassanoJ. MehndirattaM.M. MenezesR.G. MeretojaA. MohajerB. IbrahimM.N. MohammadY. MohammedA. MokdadA.H. MondelloS. MoniM.A.A. MoniruzzamanM. MossieT.B. NagelG. NaveedM. NayakV.C. KandelN.S. NguyenT.H. OanceaB. OtstavnovN. OtstavnovS.S. OwolabiM.O. Panda-JonasS. KanP.F. PasovicM. PatelU.K. PathakM. PeresM.F.P. PerianayagamA. PetersonC.B. PhillipsM.R. PinheiroM. PiradovM.A. PondC.D. PotashmanM.H. PottooF.H. PradaS.I. RadfarA. RaggiA. RahimF. RahmanM. RamP. RanasingheP. RawafD.L. RawafS. RezaeiN. RezapourA. RobinsonS.R. RomoliM. RoshandelG. SahathevanR. SahebkarA. SahraianM.A. SathianB. SattinD. SawhneyM. SaylanM. SchiavolinS. SeylaniA. ShaF. ShaikhM.A. ShajiK.S. ShannawazM. ShettyJ.K. ShigematsuM. ShinJ.I. ShiriR. SilvaD.A.S. SilvaJ.P. SilvaR. SinghJ.A. SkryabinV.Y. SkryabinaA.A. SmithA.E. SoshnikovS. SpurlockE.E. SteinD.J. SunJ. Tabarés-SeisdedosR. ThakurB. TimalsinaB. Tovani-PaloneM.R. TranB.X. TsegayeG.W. TahbazV.S. ValdezP.R. VenketasubramanianN. VlassovV. VuG.T. VuL.G. WangY-P. WimoA. WinklerA.S. YadavL. JabbariY.S.H. YamagishiK. YangL. YanoY. YonemotoN. YuC. YunusaI. ZadeyS. ZastrozhinM.S. ZastrozhinaA. ZhangZ-J. MurrayC.J.L. VosT. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019.Lan. Pub. Health202272e105e12510.1016/S2468‑2667(21)00249‑834998485
    [Google Scholar]
  46. LiX. FengX. SunX. HouN. HanF. LiuY. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2019.Front. Aging Neurosci.20221493748610.3389/fnagi.2022.93748636299608
    [Google Scholar]
  47. SeitzD.P. BrisbinS. HerrmannN. RapoportM.J. WilsonK. GillS.S. RinesJ. ClairL.K. ConnD. Efficacy and feasibility of nonpharmacological interventions for neuropsychiatric symptoms of dementia in long term care: A systematic review.J. Am. Med. Dir. Assoc.2012136503506.e210.1016/j.jamda.2011.12.05922342481
    [Google Scholar]
  48. SpectorA. ThorgrimsenL. WoodsB. RoyanL. DaviesS. ButterworthM. OrrellM. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia.Br. J. Psychiatry2003183324825410.1192/bjp.183.3.24812948999
    [Google Scholar]
  49. ZhongD. ChenL. FengY. SongR. HuangL. LiuJ. ZhangL. Effects of virtual reality cognitive training in individuals with mild cognitive impairment: A systematic review and meta-analysis.Int. J. Geriatr. Psychiatry202136121829184710.1002/gps.560334318524
    [Google Scholar]
  50. SrivastavaP. TripathiP.N. SharmaP. RaiS.N. SinghS.P. SrivastavaR.K. ShankarS. ShrivastavaS.K. Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory.Eur. J. Med. Chem.201916316311613510.1016/j.ejmech.2018.11.04930503937
    [Google Scholar]
  51. TripathiP.N. SrivastavaP. SharmaP. TripathiM.K. SethA. TripathiA. RaiS.N. SinghS.P. ShrivastavaS.K. Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory.Bioorg. Chem.201985829610.1016/j.bioorg.2018.12.01730605887
    [Google Scholar]
  52. SinghM. AgarwalV. PanchamP. JindalD. AgarwalS. RaiS. SinghS. GuptaV. A comprehensive review and androgen deprivation therapy and its impact on Alzheimer’s disease risk in older men with prostate cancer.Degener. Neurol. Neuromuscul. Dis.20241414334610.2147/DNND.S44513038774717
    [Google Scholar]
  53. RaiS.N. SinghC. SinghA. SinghM.P. SinghB.K. Mitochondrial dysfunction: A potential therapeutic target to treat Alzheimer’s disease.Mol. Neurobiol.20205773075308810.1007/s12035‑020‑01945‑y32462551
    [Google Scholar]
  54. TripathiP. LodhiA. RaiS. NandiN. DumogaS. YadavP. TiwariA. SinghS. El-ShorbagiA.N. ChaudharyS. Review of pharmacotherapeutic targets in Alzheimer’s disease and its management using traditional medicinal plants.Degener. Neurol. Neuromuscul. Dis.20241414477410.2147/DNND.S45200938784601
    [Google Scholar]
  55. BleibelM. CheikhE.A. SadierN.S. Abou-AbbasL. The effect of music therapy on cognitive functions in patients with Alzheimer’s disease: A systematic review of randomized controlled trials.Alzheimers Res. Ther.20231516510.1186/s13195‑023‑01214‑936973733
    [Google Scholar]
  56. BlackmanJ. SwirskiM. ClynesJ. HardingS. LengY. CoulthardE. Pharmacological and non-pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer's disease: A systematic review.J. Sleep Res.2021304e1322910.1111/jsr.13229
    [Google Scholar]
  57. Cámara-CalmaestraR. Martínez-AmatA. Aibar-AlmazánA. Hita-ContrerasF. HernandoM.D.N. Achalandabaso-OchoaA. Effectiveness of physical exercise on Alzheimer’s disease. A systematic review.J. Prev. Alzheimers Dis.20229460161610.14283/jpad.2022.5736281664
    [Google Scholar]
  58. HuynhQ.S. ElangovanS. HolsingerR.M.D. Non-pharmacological therapeutic options for the treatment of Alzheimer’s disease.Int. J. Mol. Sci.202223191103710.3390/ijms23191103736232336
    [Google Scholar]
  59. KimD. The effects of a recollection-based occupational therapy program of Alzheimer's disease: A randomized controlled trial.Occup. Ther. Int.20202020630572710.1155/2020/6305727
    [Google Scholar]
  60. LökN. BademliK. Selçuk-TosunA. The effect of reminiscence therapy on cognitive functions, depression, and quality of life in Alzheimer patients: Randomized controlled trial.Int. J. Geriatr. Psychiatry2019341475310.1002/gps.498030246408
    [Google Scholar]
  61. LyuJ. ZhangJ. MuH. LiW. ChampM. XiongQ. GaoT. XieL. JinW. YangW. CuiM. GaoM. LiM. The effects of music therapy on cognition, psychiatric symptoms, and activities of daily living in patients with Alzheimer’s disease.J. Alzheimers Dis.20186441347135810.3233/JAD‑18018329991131
    [Google Scholar]
  62. MatziorinisA.M. KoelschS. The promise of music therapy for Alzheimer’s disease: A review.Ann. N. Y. Acad. Sci.202215161111710.1111/nyas.1486435851957
    [Google Scholar]
  63. TheleritisC. SiarkosK. KatirtzoglouE. PolitisA. Pharmacological and nonpharmacological treatment for apathy in Alzheimer disease.J. Geriatr. Psychiatry Neurol.2017301264910.1177/089198871667868428248559
    [Google Scholar]
  64. ZhuS. SuiY. ShenY. ZhuY. AliN. GuoC. WangT. Effects of virtual reality intervention on cognition and motor function in older adults with mild cognitive impairment or dementia: A systematic review and meta-analysis.Front. Aging Neurosci.20211358699910.3389/fnagi.2021.58699934025384
    [Google Scholar]
  65. RobertP. BenoitM. RachidG. Pierre-DavidP. EmmanuelleC. ValeriaM. ChaurasiaG. GeorgeD. Is it possible to use highly realistic virtual reality in the elderly? A feasibility study with image-based rendering.Neuropsychiatr. Dis. Treat.20151155756310.2147/NDT.S7317925834437
    [Google Scholar]
  66. LarsonE.B. FeigonM. GagliardoP. DvorkinA.Y. Virtual reality and cognitive rehabilitation: A review of current outcome research.NeuroRehabilitation201434475977210.3233/NRE‑14107824820166
    [Google Scholar]
  67. Gatica-RojasV. Méndez-RebolledoG. Virtual reality interface devices in the reorganization of neural networks in the brain of patients with neurological diseases.Neural Regen. Res.20149888889610.4103/1673‑5374.13161225206907
    [Google Scholar]
  68. HamadA. JiaB. How virtual reality technology has changed our lives: An overview of the current and potential applications and limitations.Int. J. Environ. Res. Public Health202219181127810.3390/ijerph19181127836141551
    [Google Scholar]
  69. YiannopoulouK.G. PapageorgiouS.G. Current and future treatments in Alzheimer disease: An update.J. Cent. Nerv. Syst. Dis.20201210.1177/117957352090739710.1177/117957352090739732165850
    [Google Scholar]
  70. DierschN. WolbersT. The potential of virtual reality for spatial navigation research across the adult lifespan.J. Exp. Biol.2019222Pt Suppl 1jeb18725210.1242/jeb.187252
    [Google Scholar]
  71. AllainP. FoloppeD.A. BesnardJ. YamaguchiT. Etcharry-BouyxF. GallL.D. NolinP. RichardP. Detecting everyday action deficits in Alzheimer’s disease using a nonimmersive virtual reality kitchen.J. Int. Neuropsychol. Soc.201420546847710.1017/S135561771400034424785240
    [Google Scholar]
  72. DonigerG.M. BeeriM.S. Bahar-FuchsA. GottliebA. TkachovA. KenanH. LivnyA. BahatY. SharonH. Ben-GalO. CohenM. ZeiligG. PlotnikM. Virtual reality-based cognitive-motor training for middle-aged adults at high Alzheimer’s disease risk: A randomized controlled trial.Alzheimers Dement.20184111812910.1016/j.trci.2018.02.00529955655
    [Google Scholar]
  73. JonsonM. AvramescuS. ChenD. AlamF. The role of virtual reality in screening, diagnosing, and rehabilitating spatial memory deficits.Front. Hum. Neurosci.20211562881810.3389/fnhum.2021.62881833613216
    [Google Scholar]
  74. LiuY. TanW. ChenC. LiuC. YangJ. ZhangY. A review of the application of virtual reality technology in the diagnosis and treatment of cognitive impairment.Front. Aging Neurosci.20191128010.3389/fnagi.2019.0028031680934
    [Google Scholar]
  75. MillerH.L. BugnariuN.L. Level of immersion in virtual environments impacts the ability to assess and teach social skills in autism spectrum disorder.Cyberpsychol. Behav. Soc. Netw.201619424625610.1089/cyber.2014.068226919157
    [Google Scholar]
  76. García-BetancesR.I. WaldmeyerA.M.T. FicoG. Cabrera-UmpiérrezM.F. A succinct overview of virtual reality technology use in Alzheimer’s disease.Front. Aging Neurosci.201578010.3389/fnagi.2015.0008026029101
    [Google Scholar]
  77. BakerR. BellS. BakerE. HollowayJ. PearceR. DowlingZ. ThomasP. AsseyJ. WareingL-A. WareingL.A. A randomized controlled trial of the effects of multi-sensory stimulation (MSS) for people with dementia.Br. J. Clin. Psychol.2001401819610.1348/01446650116350811317951
    [Google Scholar]
  78. CoyleH. TraynorV. SolowijN. Computerized and virtual reality cognitive training for individuals at high risk of cognitive decline: Systematic review of the literature.Am. J. Geriatr. Psychiatry201523433535910.1016/j.jagp.2014.04.00924998488
    [Google Scholar]
  79. OliveiraJ. GamitoP. SoutoT. CondeR. FerreiraM. CorotneanT. FernandesA. SilvaH. NetoT. Virtual reality-based cognitive stimulation on people with mild to moderate dementia due to alzheimer’s disease: A pilot randomized controlled trial.Int. J. Environ. Res. Public Health20211810529010.3390/ijerph1810529034065698
    [Google Scholar]
  80. VerkaikR. WeertV.J.C.M. FranckeA.L. The effects of psychosocial methods on depressed, aggressive and apathetic behaviors of people with dementia: A systematic review.Int. J. Geriatr. Psychiatry200520430131410.1002/gps.127915799081
    [Google Scholar]
  81. MorenoA. WallK.J. ThangaveluK. CravenL. WardE. DissanayakaN.N. A systematic review of the use of virtual reality and its effects on cognition in individuals with neurocognitive disorders.Alzheimers Dement.20195183485010.1016/j.trci.2019.09.01631799368
    [Google Scholar]
  82. Sánchez-NietoD. Castaño-CastañoS. Navarro-MartosR. Obrero-GaitánE. Cortés-PérezI. Nieto-EscamezF. An intervention on anxiety symptoms in moderate Alzheimer’s disease through virtual reality: A feasibility study and lessons learned.Int. J. Environ. Res. Public Health2023203272710.3390/ijerph2003272736768091
    [Google Scholar]
  83. KimJ. LeeJ. KimY. NuseibehB. HanS. The effects of a nature-based virtual reality program on emotional health and quality of life among older adults with dementia.Am. J. Health Behav.202347131210.5993/AJHB.47.1.136945101
    [Google Scholar]
  84. AppelL. AliS. NaragT. MozesonK. PasatZ. Orchanian-CheffA. CamposJ.L. Virtual reality to promote wellbeing in persons with dementia: A scoping review.J. Rehabil. Assist. Technol. Eng.202182055668321105395210.1177/20556683211053952
    [Google Scholar]
  85. LasaponaraS. MarsonF. DoricchiF. CavalloM. A scoping review of cognitive training in neurodegenerative diseases via computerized and virtual reality tools: What we know so far.Brain Sci.202111552810.3390/brainsci1105052833919244
    [Google Scholar]
  86. MaggioM.G. BenenatiA. ImpellizzeriF. RizzoA. BarberaM. CannavòA. GregoliV. MoroneG. ChiricoF. QuartaroneA. CalabròR.S. Impact of cognitive vr vs. traditional training on emotional self-efficacy and cognitive function in patients with multiple sclerosis: A retrospective study focusing on gender differences.Brain Sci.20241412122710.3390/brainsci1412122739766426
    [Google Scholar]
  87. MarottaN. CalafioreD. CurciC. LippiL. AmmendoliaV. FerraroF. InvernizziM. SIRED.A. Integrating virtual reality and exergaming in cognitive rehabilitation of patients with Parkinson disease: A systematic review of randomized controlled trials.Eur. J. Phys. Rehabil. Med.202358681882610.23736/S1973‑9087.22.07643‑236169933
    [Google Scholar]
  88. SofaerN. StrechD. The need for systematic reviews of reasons.Bioethics201226631532810.1111/j.1467‑8519.2011.01858.x21521251
    [Google Scholar]
  89. BueleJ. Varela-AldásJ.L. Palacios-NavarroG. Virtual reality applications based on instrumental activities of daily living (iADLs) for cognitive intervention in older adults: A systematic review.J. Neuroeng. Rehabil.202320116810.1186/s12984‑023‑01292‑838110970
    [Google Scholar]
  90. ChenX. LiuF. LinS. YuL. LinR. Effects of virtual reality rehabilitation training on cognitive function and activities of daily living of patients with poststroke cognitive impairment: A systematic review and meta-analysis.Arch. Phys. Med. Rehabil.202210371422143510.1016/j.apmr.2022.03.01235417757
    [Google Scholar]
  91. ClayF. HowettD. FitzGeraldJ. FletcherP. ChanD. PriceA. Use of immersive virtual reality in the assessment and treatment of Alzheimer’s disease: A systematic review.J. Alzheimers Dis.2020751234310.3233/JAD‑19121832280091
    [Google Scholar]
  92. HaoJ. LiY. SwansonR. ChenZ. SiuK.C. Effects of virtual reality on physical, cognitive, and psychological outcomes in cancer rehabilitation: A systematic review and meta-analysis.Support. Care Cancer202331211210.1007/s00520‑022‑07568‑436633695
    [Google Scholar]
  93. KruseC.S. SenK. ArmentaV. HubbardN. BrooksR. Leveraging mhealth and virtual reality to improve cognition for Alzheimer’s patients: A systematic review.Healthcare20221010184510.3390/healthcare1010184536292292
    [Google Scholar]
  94. SonC. ParkJ.H. Ecological effects of VR-based cognitive training on ADL and IADL in MCI and AD patients: A systematic review and meta-analysis.Int. J. Environ. Res. Public Health202219231587510.3390/ijerph19231587536497946
    [Google Scholar]
  95. YiY. HuY. CuiM. WangC. WangJ. Effect of virtual reality exercise on interventions for patients with Alzheimer’s disease: A systematic review.Front. Psychiatry202213106216210.3389/fpsyt.2022.106216236440413
    [Google Scholar]
  96. ZhuX.C. YuY. WangH.F. JiangT. CaoL. WangC. WangJ. TanC.C. MengX.F. TanL. YuJ.T. Physiotherapy intervention in Alzheimer’s disease: Systematic review and meta-analysis.J. Alzheimers Dis.201544116317410.3233/JAD‑14137725201787
    [Google Scholar]
  97. ZhangQ. FuY. LuY. ZhangY. HuangQ. YangY. ZhangK. LiM. Impact of virtual reality-based therapies on cognition and mental health of stroke patients: Systematic review and meta-analysis.J. Med. Internet Res.20212311e3100710.2196/3100734787571
    [Google Scholar]
  98. MoherD. LiberatiA. TetzlaffJ. AltmanD.G. PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement.PLoS Med.200967e100009710.1371/journal.pmed.100009719621072
    [Google Scholar]
  99. HofmannM. RöslerA. SchwarzW. Müller-SpahnF. KräuchiK. HockC. SeifritzE. Interactive computer-training as a therapeutic tool in Alzheimer’s disease.Compr. Psychiatry200344321321910.1016/S0010‑440X(03)00006‑312764709
    [Google Scholar]
  100. HwangJ. LeeS. The effect of virtual reality program on the cognitive function and balance of the people with mild cognitive impairment.J. Phys. Ther. Sci.20172981283128610.1589/jpts.29.128328878448
    [Google Scholar]
  101. KangJ.M. KimN. LeeS.Y. WooS.K. ParkG. YeonB.K. ParkJ.W. YounJ.H. RyuS.H. LeeJ.Y. ChoS.J. Effect of cognitive training in fully immersive virtual reality on visuospatial function and frontal-occipital functional connectivity in predementia: Randomized controlled trial.J. Med. Internet Res.2021235e2452610.2196/2452633955835
    [Google Scholar]
  102. MaengS. HongJ.P. KimW.H. KimH. ChoS.E. KangJ.M. NaK.S. OhS.H. ParkJ.W. BaeJ.N. ChoS.J. Effects of virtual reality-based cognitive training in the elderly with and without mild cognitive impairment.Psychiatry Investig.202118761962710.30773/pi.2020.044634265200
    [Google Scholar]
  103. MasoumzadehS. MoussaviZ. Does practicing with a virtual reality driving simulator improve spatial cognition in older adults? a pilot study.Neurosci. Insights202015263310552096793010.1177/263310552096793035174332
    [Google Scholar]
  104. SerinoS. PedroliE. TuenaC. LeoD.G. Stramba-BadialeM. GouleneK. MariottiN.G. RivaG. A novel virtual reality-based training protocol for the enhancement of the “mental frame syncing” in individuals with Alzheimer’s disease: A development-of-concept trial.Front. Aging Neurosci.2017924010.3389/fnagi.2017.0024028798682
    [Google Scholar]
  105. ArnsL.L. CerneyM.M. The Relationship Between Age and Incidence of Cybersickness among Immersive Environment Users.Proceedings of the 2005 IEEE Conference 2005 on Virtual Reality (VR’05)2005, pp. 267-268.10.1109/VR.2005.80
    [Google Scholar]
  106. MartirosovS. BurešM. ZítkaT. Cyber sickness in low-immersive, semi-immersive, and fully immersive virtual reality.Virtual Real.2022261153210.1007/s10055‑021‑00507‑434025203
    [Google Scholar]
  107. ScalesK. ZimmermanS. MillerS.J. Evidence-based nonpharmacological practices to address behavioral and psychological symptoms of dementia.Gerontologist201858Suppl. 1S88S10210.1093/geront/gnx16729361069
    [Google Scholar]
  108. Cano-de-la-CuerdaR. Blázquez-FernándezA. Marcos-AntónS. Sánchez-Herrera-BaezaP. Fernández-GonzálezP. Collado-VázquezS. Jiménez-AntonaC. Laguarta-ValS. Economic cost of rehabilitation with robotic and virtual reality systems in people with neurological disorders: A systematic review.J. Clin. Med.2024136153110.3390/jcm13061531
    [Google Scholar]
/content/journals/car/10.2174/0115672050374807250224044204
Loading
/content/journals/car/10.2174/0115672050374807250224044204
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test